Signaling Protein Networks as Targets of New Antineoplastic Drugs

International Journal of Biological Markers - Italy
doi 10.1177/172460080301800110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Clinical Pharmacology of Antineoplastic Drugs

British Journal of Cancer
Cancer ResearchOncology
1979English

WNK-Signaling Inhibitors as Potential New Antihypertensive Drugs

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2017English

New Drugs for Old Targets

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

New Drugs for New Targets in Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

G-Protein-Coupled Receptors as Signaling Targets for Antiplatelet Therapy

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2009English

Histone Deacetylases as Targets for Antitrypanosomal Drugs

Future Science OA
MedicineBiotechnology
2018English

Inteins as Targets for Potential Antimycobacterial Drugs

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2003English

Regulators of G-Protein Signaling in the Heart and Their Potential as Therapeutic Targets

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2011English

TGF-β1 Signaling Targets Metastasis-Associated Protein 1, a New Effector in Epithelial Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy